# Exeltis USA, Inc. – FDA Inspection, Jun 6, 2017

Source: https://www.keypedia.com/records/fda_inspections/exeltis-usa-inc/9ab7c541-da1d-41e2-8960-4fde32f2506c
Source feed: FDA_Inspections

> FDA inspection 1014140 of Exeltis USA, Inc., June 06, 2017. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR parts 111 and 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014140
- Company Name: Exeltis USA, Inc.
- Inspection Date: 2017-06-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- FDA Inspection 1333134 - 2026-09-22
- FDA Inspection 1250586 - 2025-07-02
- FDA Inspection 1232731 - 2024-11-15
- FDA Inspection 1076534 - 2019-01-14

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/emmanuel-j-ramos/ba0666bd-2752-453e-9fd3-5e43b1cff3ad)
- [FDA Associated Person](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)

Company: https://www.keypedia.com/companies/exeltis-usa-inc/d5a2dfa6-39bc-4768-b3f4-5c0630d2dc8f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c